---
schema_version: "secwatch.filing_event.v1"
accession: "0001404644-26-000050"
form_type: "8-K"
ticker: "NGNE"
cik: "0001404644"
company_name: "Neurogene Inc."
filed_at: "2026-07-02T00:02:10+00:00"
generated_at: "2026-07-02T10:05:23.088444+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Neurogene raises ~$134.8M in public offering of common stock and pre-funded warrants

## Summary
- Issued 3.5M shares at $30.00 and pre-funded warrants for 666,666 shares at $29.999999.
- Underwriters exercised option for additional 624,999 shares; total net proceeds ~$134.8M.
- Offering expected to close July 2, 2026; proceeds plus existing cash fund operations into Q1 2029.
- Pre-funded warrants exercisable immediately, subject to 4.99%/9.99% beneficial ownership limitation.

## SEC filing metadata
- accession: 0001404644-26-000050
- form_type: 8-K
- ticker: NGNE
- cik: 0001404644
- company_name: Neurogene Inc.
- filed_at: 2026-07-02T00:02:10+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404644/000140464426000050/0001404644-26-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404644/000140464426000050/ngne-20260630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001404644-26-000050
- JSON: https://secwatch.observer/filing/0001404644-26-000050.json
- Plain text: https://secwatch.observer/filing/0001404644-26-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.